HURA (TuHURA Biosciences) Moat Score: 2/10 (As of Jun. 29, 2026)


HURA TuHURA Biosciences Inc HURA
12 GF Score
Price $2.24
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Moat Score?

TuHURA Biosciences HURA +0.67% 12 Moat Score is 2 as of Jun. 29, 2026. GuruFocus rates HURA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 1,401 Biotechnology companies, TuHURA Biosciences ranks better than 58.1% on this metric.

TuHURA Biosciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

TuHURA Biosciences has No Moat: TuHURA Biosciences operates in a competitive biotech industry with high R&D costs and low switching costs. The company lacks significant intellectual property, brand strength, or market share, resulting in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TuHURA Biosciences might have No Moat - Very weak/transient advantages.

TuHURA Biosciences  (NAS:HURA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TuHURA Biosciences Moat Score Related Terms

HURA vs ACOG, MENS, ENLV: Moat Score Comparison

For the Biotechnology subindustry, TuHURA Biosciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Moat Score distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Moat Score falls into.


HURA
12GF Score
TuHURA Biosciences Inc HURA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
TuHURA Biosciences (HURA) has a Moat Score of 2 as of Jun. 29, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, TuHURA Biosciences ranks #587 out of 1401 companies in the Biotechnology industry, placing it in the top 41.9%.
Is TuHURA Biosciences' Moat Score too high?
TuHURA Biosciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. TuHURA Biosciences' value of 2 is 0% at this industry median. Based on the distribution chart, TuHURA Biosciences ranks #587 out of 1401 companies in the Biotechnology industry, which is above the industry midpoint. Overall, TuHURA Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Moat Score compare to ACOG and MENS?
According to the Biotechnology industry distribution chart, TuHURA Biosciences ranks #587 out of 1401 companies for Moat Score. This puts TuHURA Biosciences in the upper half of its industry. The industry median Moat Score is 2.00. TuHURA Biosciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,401 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TuHURA Biosciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TuHURA Biosciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (HURA) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. TuHURA Biosciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For TuHURA Biosciences (HURA), the current Moat Score is 2 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges PL3:Germany
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
12GF Score

Get the complete analysis for HURA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.24
Price